Overview
- 25 inspections across 24 sites are on record.
- 49 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-01-30.
At a glance
Inspections
25
Sites
24
Observations
49
Career since
Aug 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| BioRamo, LLC | 30 Jan 2025 | Human Drugs | View 483 → |
| Sipra Labs Limited | 27 Sep 2024 | Human Drugs | On file |
| Aarti Drugs Ltd | 20 Sep 2024 | Human Drugs | On file |
| Universitat de Barcelona | 27 Jun 2024 | Human Drugs | On file |
| CELINDE LABORATORIOS | 21 Jun 2024 | Human Drugs | On file |
Sites inspected
BioRamo, LLCFt Lauderdale, United States1 insp.
Sipra Labs LimitedHyderabad, India1 insp.
Aarti Drugs LtdPalghar, India1 insp.
Universitat de BarcelonaBarcelona, Spain1 insp.
CELINDE LABORATORIOSZaragoza, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Damaris Y Hernandez3 shared
Lori B Wikstrom3 shared
Taichun Qin3 shared
Rajiv R Srivastava2 shared
Kayla V Sprague2 shared
Cynthia Jim2 shared
Nicole E Knowlton2 shared
Lillian M Colon-Mcknight2 shared
Joanne E King2 shared
Megan T Ziegler1 shared
Full investigator report
Get the verbatim findings behind Suzanne N Vallez's 49 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site